Condition
Blood Clots
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Terminated1
Not Yet Recruiting1
Completed1
Withdrawn1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02108041Completed
Personalized Medicine Decision-Making in a Virtual Clinical Setting
NCT06975969WithdrawnPrimary
Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter
NCT07378514Not Yet RecruitingPrimary
Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices
NCT03805672Phase 4Terminated
Below Knee DVT Study
Showing all 4 trials